Skip to Content
Merck
  • Synergistic cooperation of MDM2 and E2F1 contributes to TAp73 transcriptional activity.

Synergistic cooperation of MDM2 and E2F1 contributes to TAp73 transcriptional activity.

Biochemical and biophysical research communications (2014-05-23)
Vivi Kasim, Can Huang, Jing Zhang, Huizhen Jia, Yunxia Wang, Li Yang, Makoto Miyagishi, Shourong Wu
ABSTRACT

TAp73, a structural homologue of p53, plays an important role in tumorigenesis. E2F1 had been reported as a transcriptional regulator of TAp73, however, the detailed mechanism remains to be elucidated. Here we reported that MDM2-silencing reduced the activities of the TAp73 promoters and the endogenous TAp73 expression level significantly; while MDM2 overexpression upregulated them. We further revealed that the regulation of TAp73 transcriptional activity occurs as a synergistic effect of MDM2 and E2F1, most probably through their physical interaction in the nuclei. Furthermore, we also suggested that MDM2 might be involved in DNA damage-induced TAp73 transcriptional activity. Finally, we elucidated that MDM2-silencing reduced the proliferation rate of colon carcinoma cells regardless of the p53 status. Our data show a synergistic effect of MDM2 and E2F1 on TAp73 transcriptional activity, suggesting a novel regulation pathway of TAp73.

MATERIALS
Product Number
Brand
Product Description

Roche
X-tremeGENE HP DNA Transfection Reagent, High-performance polymer reagent for transfecting many cell lines